Copyright (c) 2018 AJC
This work is licensed under a Creative Commons Attribution 4.0 International License.
Synthesis and Evaluation of Prodrugs of Ketoprofen with Antioxidants as Gastroprotective NSAIDs
Corresponding Author(s) : Rajesh K. Singh
Asian Journal of Chemistry,
Vol. 30 No. 9 (2018): Vol 30 Issue 9
Abstract
Ketoprofen-antioxidant mutual prodrugs were synthesized to reduce the gastrointestinal effects associated with ketoprofen. For reducing the gastrointestinal toxicity, the free carboxylic group (–COOH) was temporarily masked by esterification with alcoholic/phenolic –OH of natural antioxidants thymol, guaiacol, menthol and vanillin. In order to obtain the derivatives with improved in vivo lability, the double ester prodrugs i.e. ketoprofen-antioxidant through the glycolic acid spacer (-CH2COO-) have been synthesized. These mutual prodrugs were evaluated for their anti-inflammatory, analgesic and antiulcer properties. The results indicate that there is merit to extend the therapeutic utility of this potential NSAID by developing the ketoprofen-antioxidant mutual prodrugs as gastroprotective NSAIDs.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- C. Martin, A. Connelly, T.O. Keku, S.B. Mountcastle, J. Galanko, J.T. Woosley, B. Schliebe, P.K. Lund and R.S. Sandler, Gastroenterology, 123, 1770 (2002); https://doi.org/10.1053/gast.2002.37053.
- S.K. Suthar and M. Sharma, Mini Rev. Med. Chem., 16, 1201 (2016); https://doi.org/10.2174/1389557516666160428111419.
- J.M. Scheiman and C.E. Hindley, Clin. Ther., 32, 667 (2010); https://doi.org/10.1016/j.clinthera.2010.04.009.
- M. Lazzaroni, A. Battocchia and G.B. Porro, Dig. Liver Dis., 39, 589 (2007); https://doi.org/10.1016/j.dld.2007.04.002.
- T. Mizushima, Pharmaceuticals, 3, 1614 (2010); https://doi.org/10.3390/ph3051614.
- R.M. Langford, Clin. Rheumatol., 25, 2 (2006); https://doi.org/10.1007/s10067-006-0311-5.
- M. Fine, Am. J. Manag. Care, 19, 267 (2013).
- J.H. Lewis J.G. Stine, Non-Steroidal Anti-Inflammatory Drugs and Leukotriene Receptor Antagonists: Pathology and Clinical Presentation of Hepatotoxicity, Elsevier: Amsterdam, edn 3, pp. 370-402 (2013).
- J,.R. Vane and R.M. Botting, Therapeutic Roles of Selective COX-2 Inhibitors. William Harvey, London (2001).
- M. Rodriguez-Tellez, F. Arguelles, J. Herrerias Jr., D. Ledro, J. Esteban and J. Herrerias, Curr. Pharm. Des., 7, 951 (2001); https://doi.org/10.2174/1381612013397663.
- T. Brzozowski, P.C. Konturek, S.J. Konturek, R. Pajdo, W. Bielanski, I. Brzozowska, J. Stachura and E.G. Hahn, J. Pineal Res., 23, 79 (1997); https://doi.org/10.1111/j.1600-079X.1997.tb00339.x.
- S. Sehajpal, D.N. Prasad and R.K. Singh, Mini-Review Med. Chem., 18, 1199 (2018); https://doi.org/10.2174/1389557518666180330112416.
- J.F. Herrero, A. Parrado and F. Cervero, Neuropharmacology, 36, 1425 (1997); https://doi.org/10.1016/S0028-3908(97)00120-2.
- D. Brambilla, C. Mancusa, M.R. Scuderi, P. Bosco, G. Cantarella, L. Lempereur, G. Di Benedetto, S. Pezzino and R. Bernardini, Nutr. J., 7, 29 (2008); https://doi.org/10.1186/1475-2891-7-29.
- S. Srivastava, P. Gupta, A. Sethi and R.P. Singh, J. Mol. Struct., 1117, 173 (2016); https://doi.org/10.1016/j.molstruc.2016.03.033.
- S.S. Dhaneshwar, D. Bhosle, S. Bharambe and N. Gairola, Indian J. Pharm. Sci., 68, 286 (2006); https://doi.org/10.4103/0250-474X.26654.
- A.M. Qandil, M.M. Rezigue and B.M. Tashtoush, Eur. J. Pharm. Sci., 43, 99 (2011); https://doi.org/10.1016/j.ejps.2011.03.012.
- Z. Ashraf, K.M. Alamgeer, M. Hassan, S. Abdullah, M. Waheed, H. Ahsan and S.J. Kim, Drug Des. Devel. Ther., 10, 2401 (2016); https://doi.org/10.2147/DDDT.S109318.
- M. Gordon, Nat. Prod. Rep., 13, 265 (1996); https://doi.org/10.1039/np9961300265.
- B. Manon and P.D. Sharma, Indian J. Chem., 48B, 1279 (2009).
- V.K. Redasani and S.B. Bari, Eur. J. Med. Chem., 56, 134 (2012); https://doi.org/10.1016/j.ejmech.2012.08.030.
- A. Rasheed, G. Lathika, Y.P. Raju, K.P. Mansoor, A.K. Azeem and N. Balan, Med. Chem. Res., 25, 70 (2016); https://doi.org/10.1007/s00044-015-1469-7.
- N. Sharma, A.K. Sahdev and V. Raj, Org. Med. Chem. Int. J., 2, 1 (2017).
- K. Shah, S.K. Shrivastava and P. Mishra, Med. Chem. Res., 22, 70 (2013); https://doi.org/10.1007/s00044-012-0016-z.
- P.D. Sharma and G. Kaur, Indian J. Chem., 43B, 2159 (2004).
- E.M. Valter, M.M.M. Lucas, E.P.S. Gloria and R.M.O. Anderson, J. Braz. Chem. Soc., 27, 1121 (2016); https://doi.org/10.5935/0103-5053.20160005.
- C.A. Winter, G.A. Risley and G.W. Nuss, Proc. Soc. Exp. Biol. Med., 111, 544 (1962); https://doi.org/10.3181/00379727-111-27849.
- R. Koster, M. Anderson and E.J. De-Beer, Fed. Proc., 18, 412 (1959).
- S.K. Kulkarni, Handbook of Experimental Pharmacology, Vallabh Prakashan, Delhi, India, edn 3, 125 (2005).
- N.K. Jain, C.S. Patil, R.E. Kartasasmita, M. Decker, J. Lehmann and S.K. Kulkarni, Drug Dev. Res., 61, 66 (2004); https://doi.org/10.1002/ddr.10337.
- J. Rautio, T. Nevalainen, H. Taipale, J. Vepsäläinen, J. Gynther, K. Laine and T. Järvinen, Eur. J. Pharm. Sci., 11, 157 (2000); https://doi.org/10.1016/S0928-0987(00)00090-7.
- M. Anitha, G. Sakthidevi, S. Muthukumarasamy and V.R. Moha, Int. J. Chem. Pharm. Sci., 3, 53 (2012).
References
C. Martin, A. Connelly, T.O. Keku, S.B. Mountcastle, J. Galanko, J.T. Woosley, B. Schliebe, P.K. Lund and R.S. Sandler, Gastroenterology, 123, 1770 (2002); https://doi.org/10.1053/gast.2002.37053.
S.K. Suthar and M. Sharma, Mini Rev. Med. Chem., 16, 1201 (2016); https://doi.org/10.2174/1389557516666160428111419.
J.M. Scheiman and C.E. Hindley, Clin. Ther., 32, 667 (2010); https://doi.org/10.1016/j.clinthera.2010.04.009.
M. Lazzaroni, A. Battocchia and G.B. Porro, Dig. Liver Dis., 39, 589 (2007); https://doi.org/10.1016/j.dld.2007.04.002.
T. Mizushima, Pharmaceuticals, 3, 1614 (2010); https://doi.org/10.3390/ph3051614.
R.M. Langford, Clin. Rheumatol., 25, 2 (2006); https://doi.org/10.1007/s10067-006-0311-5.
M. Fine, Am. J. Manag. Care, 19, 267 (2013).
J.H. Lewis J.G. Stine, Non-Steroidal Anti-Inflammatory Drugs and Leukotriene Receptor Antagonists: Pathology and Clinical Presentation of Hepatotoxicity, Elsevier: Amsterdam, edn 3, pp. 370-402 (2013).
J,.R. Vane and R.M. Botting, Therapeutic Roles of Selective COX-2 Inhibitors. William Harvey, London (2001).
M. Rodriguez-Tellez, F. Arguelles, J. Herrerias Jr., D. Ledro, J. Esteban and J. Herrerias, Curr. Pharm. Des., 7, 951 (2001); https://doi.org/10.2174/1381612013397663.
T. Brzozowski, P.C. Konturek, S.J. Konturek, R. Pajdo, W. Bielanski, I. Brzozowska, J. Stachura and E.G. Hahn, J. Pineal Res., 23, 79 (1997); https://doi.org/10.1111/j.1600-079X.1997.tb00339.x.
S. Sehajpal, D.N. Prasad and R.K. Singh, Mini-Review Med. Chem., 18, 1199 (2018); https://doi.org/10.2174/1389557518666180330112416.
J.F. Herrero, A. Parrado and F. Cervero, Neuropharmacology, 36, 1425 (1997); https://doi.org/10.1016/S0028-3908(97)00120-2.
D. Brambilla, C. Mancusa, M.R. Scuderi, P. Bosco, G. Cantarella, L. Lempereur, G. Di Benedetto, S. Pezzino and R. Bernardini, Nutr. J., 7, 29 (2008); https://doi.org/10.1186/1475-2891-7-29.
S. Srivastava, P. Gupta, A. Sethi and R.P. Singh, J. Mol. Struct., 1117, 173 (2016); https://doi.org/10.1016/j.molstruc.2016.03.033.
S.S. Dhaneshwar, D. Bhosle, S. Bharambe and N. Gairola, Indian J. Pharm. Sci., 68, 286 (2006); https://doi.org/10.4103/0250-474X.26654.
A.M. Qandil, M.M. Rezigue and B.M. Tashtoush, Eur. J. Pharm. Sci., 43, 99 (2011); https://doi.org/10.1016/j.ejps.2011.03.012.
Z. Ashraf, K.M. Alamgeer, M. Hassan, S. Abdullah, M. Waheed, H. Ahsan and S.J. Kim, Drug Des. Devel. Ther., 10, 2401 (2016); https://doi.org/10.2147/DDDT.S109318.
M. Gordon, Nat. Prod. Rep., 13, 265 (1996); https://doi.org/10.1039/np9961300265.
B. Manon and P.D. Sharma, Indian J. Chem., 48B, 1279 (2009).
V.K. Redasani and S.B. Bari, Eur. J. Med. Chem., 56, 134 (2012); https://doi.org/10.1016/j.ejmech.2012.08.030.
A. Rasheed, G. Lathika, Y.P. Raju, K.P. Mansoor, A.K. Azeem and N. Balan, Med. Chem. Res., 25, 70 (2016); https://doi.org/10.1007/s00044-015-1469-7.
N. Sharma, A.K. Sahdev and V. Raj, Org. Med. Chem. Int. J., 2, 1 (2017).
K. Shah, S.K. Shrivastava and P. Mishra, Med. Chem. Res., 22, 70 (2013); https://doi.org/10.1007/s00044-012-0016-z.
P.D. Sharma and G. Kaur, Indian J. Chem., 43B, 2159 (2004).
E.M. Valter, M.M.M. Lucas, E.P.S. Gloria and R.M.O. Anderson, J. Braz. Chem. Soc., 27, 1121 (2016); https://doi.org/10.5935/0103-5053.20160005.
C.A. Winter, G.A. Risley and G.W. Nuss, Proc. Soc. Exp. Biol. Med., 111, 544 (1962); https://doi.org/10.3181/00379727-111-27849.
R. Koster, M. Anderson and E.J. De-Beer, Fed. Proc., 18, 412 (1959).
S.K. Kulkarni, Handbook of Experimental Pharmacology, Vallabh Prakashan, Delhi, India, edn 3, 125 (2005).
N.K. Jain, C.S. Patil, R.E. Kartasasmita, M. Decker, J. Lehmann and S.K. Kulkarni, Drug Dev. Res., 61, 66 (2004); https://doi.org/10.1002/ddr.10337.
J. Rautio, T. Nevalainen, H. Taipale, J. Vepsäläinen, J. Gynther, K. Laine and T. Järvinen, Eur. J. Pharm. Sci., 11, 157 (2000); https://doi.org/10.1016/S0928-0987(00)00090-7.
M. Anitha, G. Sakthidevi, S. Muthukumarasamy and V.R. Moha, Int. J. Chem. Pharm. Sci., 3, 53 (2012).